Adjuvant treatment in renal cell carcinoma.

Dizman, Nazli; Adashek, Jacob J; Hsu, JoAnn; Bergerot, Paulo G; Bergerot, Cristiane D; Pal, Sumanta K

Dizman, Nazli; Adashek, Jacob J; Hsu, JoAnn; Bergerot, Paulo G; Bergerot, Cristiane D; Pal, Sumanta K.

Affiliation

Dizman N; City of Hope Comprehensive Cancer Center, Duarte, California.
Adashek JJ; Western University of Health Sciences, College of Osteopathic Medicine of the Pacific, Pomona, California.
Hsu J; City of Hope Comprehensive Cancer Center, Duarte, California.
Bergerot PG; City of Hope Comprehensive Cancer Center, Duarte, California.
Bergerot CD; City of Hope Comprehensive Cancer Center, Duarte, California.
Pal SK; City of Hope Comprehensive Cancer Center, Duarte, California.

Clin Adv Hematol Oncol ; 16(8): 555-563, 2018 Aug.

Article in En | MEDLINE | ID: mdl-30148828

Subject(s)

Carcinoma, Renal Cell/drug therapy; Indoles/therapeutic use; Kidney Neoplasms/drug therapy; Pyrroles/therapeutic use; Carcinoma, Renal Cell/immunology; Carcinoma, Renal Cell/pathology; Chemotherapy, Adjuvant/methods; Female; Humans; Indoles/adverse effects; Kidney Neoplasms/immunology; Kidney Neoplasms/pathology; Male; Pyrroles/adverse effects; Randomized Controlled Trials as Topic; Sunitinib

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyrroles / Carcinoma, Renal Cell / Indoles / Kidney Neoplasms Type of study: Clinical_trials Limits: Female / Humans / Male Language: En Journal: Clin Adv Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2018 Type: Article

Search on Google

XML

PubMed Links